Amiodarone is known to induce drug-drug interactions with warfarin that could lead to excessive anticoagulation and bleeding risk [8,9,10,11,12]. Similar to warfarin, amiodarone is metabolized in the liver by the drug-metabolizing enzyme cytochrome P450 (CYP), which it inhibits.
Amiodarone has emerged as the most effective agent at preventing relapse of AF post-DEC, with up to 69% of patients remaining in sinus rhythm at one year. However, as many as 25% of amiodarone treated patients are forced to discontinue treatment because of side effects of the drug.
Taking blood thinners such as warfarin with amiodarone may increase the effect of the blood thinner. This puts you at risk for serious bleeding, which may be fatal. If you take these drugs together, your doctor should decrease the dosage of your blood thinner and monitor you closely.
Patients should be reviewed 6 monthly by their GP and monitored carefully for adverse effects of amiodarone therapy, particularly pulmonary toxicity and arrhythmias. U&E, TFT & LFT should also be monitored 6 monthly.
Carbamazepine is an antiepileptic drug that presumably enhances the metabolism of warfarin, thereby increasing the warfarin dose required to keep the International Normalized Ratio (INR) within the therapeutic range.
Using warfarin together with phenytoin may cause you to bleed more easily. It may also increase phenytoin levels. Phenytoin levels and prothrombin time or International Normalized Ratio (INR) should be monitored whenever the dosage is changed or discontinued.
The combination of amiodarone and warfarin potentiates the effect of warfarin and prolongs the International Normalized Ratio (INR), increasing the risk of bleeding.
However, amiodarone is associated with a number of side effects, including thyroid dysfunction (both hypo- and hyperthyroidism), which is due to amiodarone's high iodine content and its direct toxic effect on the thyroid.
The international normalized ratio (INR) is a calculation based on results of a PT and is used to monitor individuals who are being treated with the blood-thinning medication (anticoagulant) warfarin (Coumadin®). The PT and INR are used to monitor the effectiveness of the anticoagulant warfarin.
It is OK to consume alcohol if you are taking warfarin, so long as you stick to recommended guidelines for a low-risk maximum weekly alcohol intake.
Amiodarone is a potent antiarrhythmic agent that is used to treat ventricular arrhythmias and atrial fibrillation. The drug prevents the recurrence of life-threatening ventricular arrhythmias and produces a modest reduction of sudden deaths in high-risk patients.
Amiodarone is a substrate of CYP3A4 and CYP2C8 and an inhibitor of CYP2C9, CYP2D6, CYP3A4, and p-glycoprotein. Based on these assumptions, there are several potential interactions that could occur when amiodarone and bosentan are coadministered: Bosentan could induce amiodarone metabolism via CYP3A4.
After long-term oral therapy, amiodarone has a true elimination half-life between 60 and 142 days [2,3].
Vitamin K can change how warfarin works, which changes your INR. Vitamin K lowers your INR values. The lower your INR, the less time it takes for your blood to clot. A low INR means that warfarin isn't working well enough to prevent a dangerous blood clot.
Introduction: Warfarin is commonly used to treat or prevent thromboembolic events. Cranberry juice has been suggested to have an interaction with warfarin. However, there have been few reported cases of warfarin-cranberry juice interaction.
It is important that you take this medication exactly as your doctor has prescribed. Never stop taking it without consulting your doctor. This medication must be taken regularly for one to three weeks before a response is seen and for several months before the full effect occurs.
Amiodarone is well known for a myriad of side effects, some severe and life-threatening, including pulmonary toxicity, hepatotoxicity, and thyrotoxicity. One of the organs which could be affected by Amiodarone is Kidney, which, fortunately, is not a common occurrence.
Amiodarone has been associated with multiple systemic adverse effects, including bradycardia, hypothyroidism or hyperthyroidism, pulmonary toxicity, ocular deposits, and liver function derangements.
Although amiodarone is the most effective antiarrhythmic agent for maintaining sinus rhythm in patients with atrial fibrillation, it is generally used as the drug of the last resort in the United States.
More common
- Cough.
- dizziness, lightheadedness, or fainting.
- fever (slight)
- numbness or tingling in the fingers or toes.
- painful breathing.
- sensitivity of the skin to sunlight.
- trembling or shaking of the hands.
- trouble with walking.
Personal injury lawsuits have been filed against Zydus and Wyeth on behalf of patients who were seriously or fatally injured after taking Amiodarone. A class action lawsuit was also filed against Wyeth and other companies that manufactured Amiodarone.
Dronedarone has been viewed as a potential therapeutic alternative for amiodarone because of a lower risk for pulmonary, thyroid, and dermatologic adverse effects. Compared with amiodarone, dronedarone has poor bioavailability and a shorter terminal disposition half-life, which dictates a twice-daily dosing regimen.
Your doctor may decrease your dose during your treatment if you develop side effects. Follow your doctor's directions carefully. Do not stop taking amiodarone without talking to your doctor. You may need to be closely monitored or even hospitalized when you stop taking amiodarone.
Limit the amount of alcohol you drink while taking this medicine. This is because drinking alcohol while taking this medicine will increase the chance of you having problems with your liver.
So, go bananas! But be sure to eat green bananas in normal portions and make sure you keep testing your regular blood test to make sure your INR doesn't drop below your target range.
Drinking grapefruit juice, cranberry juice, and alcohol during treatment with warfarin can increase your risk of bleeding.
In order to shorten the response time for making a dosing change, patients are traditionally advised to have their INR test in the morning and to take their warfarin in the evening (so that the INR test result will be back in time to change that day's warfarin dose if needed).
The most commonly reported reasons for warfarin discontinuation were physician preference (47.7%), patient refusal/preference (21.1%), bleeding event (20.2%), frequent falls/frailty (10.8%), high bleeding risk (9.8%), and patient inability to adhere to/monitor therapy (4.7%).
Stroke can occur in patients on warfarin despite anticoagulation. Patients with a low international normalized ratio (INR) should theoretically be at greater risk for ischemia than those who are therapeutic.
A new study indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.
Today warfarin is one of the most widely prescribed oral anticoagulant drugs with around 1-2% of adults in the developed world prescribed the medication. Prior to its clinical application in the early 1950s, warfarin was used as a pesticide to kill rats and mice. It is still used for this purpose today.
Warfarin's anticoagulant effect was potentiated by 6 antibiotics (cotrimoxazole, erythromycin, fluconazole, isoniazid, metronidazole, and miconazole); 5 cardiac drugs (amiodarone, clofibrate, propafenone, propranolol, and sulfinpyrazone); phenylbutazone; piroxicam; alcohol (only with concomitant liver disease);
Warfarin oral tablet doesn't cause drowsiness. However, it can cause other side effects.
